Gerresheimer (ETR:GXI) Stock Price Up 1.7% - Should You Buy?

Gerresheimer AG (ETR:GXI - Get Free Report) traded up 1.7% during mid-day trading on Wednesday . The company traded as high as €67.80 ($70.63) and last traded at €67.80 ($70.63). 142,949 shares changed hands during mid-day trading, an increase of 1% from the average session volume of 140,925 shares. The stock had previously closed at €66.65 ($69.43).

Gerresheimer Stock Performance

The company has a market capitalization of $2.35 billion, a price-to-earnings ratio of 20.45, a P/E/G ratio of 0.82 and a beta of 0.94. The stock has a 50 day simple moving average of €70.87 and a 200 day simple moving average of €84.55. The company has a quick ratio of 0.40, a current ratio of 0.87 and a debt-to-equity ratio of 79.36.

Gerresheimer Company Profile

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.